seed
Stage
1
Investors
About
MexBrain develops MEX-CD1, a superchelating polymer medical device used with dialysis machines to extract toxic metals from the blood, targeting conditions like Wilson's Disease and Acute Kidney Injury. It is a clinical-stage company conducting pilot clinical trials in Europe.
Explore MEXBRAIN's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.